Olschewski, M., Schulgen, G., Schumacher, M., & Altman, D. G. (1994). Quality of life assessment in clinical cancer research. British Journal of Cancer, 70(1), 1–5.
Cox, D. R., & Snell, E. J. (1989). The Analysis of Binary Data (2nd ed.). London: Chapman & Hall.
Agresti, A. (2013). Categorical data analysis (3rd ed.). New York: Wiley.
Agresti, A. (2010). Analysis of ordinal categorical data (2nd ed.). New York: Wiley.
Lall, R., Campbell, M. J., Walters, S. J., Morgan, K., & MRC CFAS Co-operative. (2002). A review of ordinal regression models applied on health-related quality of life assessments. Statistical Methods in Medical Research, 11, 49–67.
Taphoorn, M. J., Stupp, R., Coens, C., Osoba, D., Kortmann, R., van den Bent, M. J., et al. (2005). Health-related quality of life in patients with glioblastoma: A randomized controlled trial. Lancet Oncology, 6(12), 937–944.
Taphoorn, M. J., van den Bent, M. J., Mauer, M., Coens, C., Delattre, J. Y., Brandes, A., et al. (2007). Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial. Journal of Clinical Oncology, 25(38), 5723–5730.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.
Taphoorn, M. J., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., et al. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer, 46, 1033–1040.
Osoba, D., Aaronson, N. K., Muller, M., Sneeuw, K., Hsu, M. A., Yung, W., et al. (1996). The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Quality of Life Research, 5(1), 139–150.
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352(10), 987–996.
Van den Bent, M. J., Carpentier, A. F., Brandes, A., Sanson, M., Taphoorn, M. J. B., Bernsen, H., et al. (2006). Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized european organisation for research and treatment of cancer phase III trial. Journal of Clinical Oncology, 24, 2715–2722.
Verbeke, G., & Molenberghs, G. (2000). Linear mixed models for longitudinal data. New York: Springer.
McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B, 42, 109–142.
Rubin, D. B. (1976). Inference and missing data. Biometrika, 63, 581–592.
Little, R. J. A., & Rubin, D. B. (1987). Statistical analysis with missing data. New-York: Wiley.
Donneau, A. F. (2013). Contribution to the statistical analysis of incomplete longitudinal ordinal data. PhD thesis, University of Liège, Belgium.
Rubin, D. B. (1978). Multiple imputation in sample surveys—A phenomenological Bayesian approach to nonresponse. Imputation and Editing of Faulty or Missing Survey Data, Washington, DC: US Department of Commerce, pp. 1–32.
Carpenter, J. R., & Kenward, M. G. (2013). Multiple imputation and its application. New York: Wiley.
Donneau, A. F., Mauer, M., Molenberghs, G., & Albert, A. (2013). A simulation study comparing multiple imputation methods for incomplete longitudinal ordinal data. Communications in Statistics—Simulation and Computation (in press).
Donneau, A. F., Mauer, M., Lambert P., Molenberghs, G., & Albert, A. (2013). Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings Journal of Biopharmaceutical Statistics (in press).
Gorlia, T., van den Bent, M. J., Hegi, M. E., Mirimanoff, R. O., Weller, M., Cairncross, J. G., et al. (2008). Nomograms for predicting survival of patients with newly diagnosed glioblastoma multiforme: A prognostic factor analysis of EORTC/NCIC trial 26981–22981/CE. The Lancet Oncology, 9, 29–38.
Rubin, D. B. (1987). Multiple imputations for nonresponse in survey. New York: Wiley.
Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., et al. (2008). EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Group Publications.
US Department of Health and Human Services Food and Drug Administration. (2006). Guidance for industry: Patient report outcome measures: use in clinical medical product development to support labelling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79.
Sprangers, M. A. G., Cull, A., Bjordal, K., et al., & for the EORTC Study Group on Quality of Life. (1994). The European Organization for Research and Treatment of Cancer approach to the quality of life (QOL) assessment: Guidelines for developing questionnaire modules. Quality of Life Research, 3, 67–68.
Horton, N., Lipsitz, S., & Parzen, M. (2003). A potential for bias when rounding in multiple imputation. The American Statistician, 57, 229–232.
Allison, P. (2005). Imputation of categorical variables with PROC MI. Paper presented at SAS Users Group International, Annual conference, Philadelphia.
